Clinical Trial

PMCF Registry to Describe the Safety and Performance of p64, p48 MW and p64 MW in France

Study acronym: CEFloW
Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate safety and performance of the phenox GmbH Flow Diverter p64, p64 MW, and p48MW in France, this registry will include subjects with intracranial aneurysms (anterior and posterior) who are treated with a phenox GmbH Flow Diverter. The subjects will be treated according to the standard of care in the participating sites.
Trial Details
NCT Number NCT07748572
Lead Sponsor Phenox GmbH
Conditions Intracranial Aneurysms
Enrollment 200 participants
Start Date 2025-03-07
Primary Completion 2028-10 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-05